Seeking Participants with Diagnosis of Stroke for Robotic Balance Training Study

The Neuromuscular Control and Human Robotics (Neurorobotics) Laboratory at Arizona State University is currently looking for stroke patients willing to participate in our stroke rehabilitation study. This program strives to assist us in our research efforts to improve rehabilitation methods for stroke survivors.

Please see the below flyer for details and more information.

Seeking Participants with Diagnosis of Stroke

(Hemiparesis) for Robotic Balance Training Study

Title: Patient-Adaptive Robotic Balance Training for Lower-Extremity Stroke Rehabilitation

Purpose: To evaluate the effectiveness of a robotic balance training in improving postural and lower body stability for stroke survivors.

Participation Criteria

Must be over 18.
Stroke needed to occur over 1 year ago.
Stroke resulted in one-sided weakness (left or right).
Should not have any acute or chronic painful condition in the upper extremities or spine.
Absence of significant motor impairment in the unimpaired limb.
Absence of visual and/or vestibular impairment.
Must be able to stand unassisted for 5 minutes.
Must not have broken any bones or injured the nerves of the back or lower extremity in the 12 months prior to participation.
Must not have had any surgeries to the back or lower extremities 12 months prior to participation.
Must not regularly experience dizziness or fainting.
Must not have been advised by their doctor to avoid exercise.
Must not be pregnant or think that they may be pregnant.
Must have no heart conditions

Study Location: Arizona State University (ASU) Tempe campus (ECC 117)

Study Duration: If you participate in this study, you will be asked to come to ASU 12 times for a 6-week training program of 2 sessions per week. Each session will last approximately 2 hours. Participation is voluntary.

Reimbursement: You will receive a $40 Target gift card each session ($480 total) for your participation in this study. We will also pay subjects’ parking fees.